Age-dependent relative and absolute benefit of radiotherapy after breast-conserving surgery: a population-based analysis using SEER data [0.03%]
基于SEER数据的乳房肿瘤局部保留手术后放疗相对疗效和绝对疗效的年龄依赖性分析
Seiichi Imanishi,Namiko Tanaka,Chisato Takeuchi et al.
Seiichi Imanishi et al.
Background: Radiotherapy (RT) after breast-conserving surgery (BCS) improves breast cancer outcomes. However, its clinical relevance may vary with age, particularly in the presence of competing risks and treatment burden....
Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study [0.03%]
2018年至2023年激素受体阳性、HER2低表达转移性乳腺癌的现实世界治疗模式和结局：一项美国队列回顾性观察研究
Erica L Mayer,Simon M Collin,Sam Hillman et al.
Erica L Mayer et al.
Purpose: To investigate real-world demographics, clinical characteristics, treatment patterns, and outcomes in US patients with ≥ 1 line of therapy (LOT) for hormone receptor-positive (HR+) HER2-low metastatic breast can...
Observational Study
Breast cancer research and treatment. 2026 Jul 20;218(2):15. DOI:10.1007/s10549-026-08029-w 2026
Clinical and molecular features of resected breast cancer brain metastases: a single center retrospective cohort study [0.03%]
可手术乳腺癌脑转移的临床和分子特征：单中心回顾性队列研究
Nira A Krasnow,Mia Salans,Michelle Jayaraj et al.
Nira A Krasnow et al.
Purpose: To characterize clinical and molecular characteristics and prognosis among patients with metastatic breast cancer (MBC) who undergo brain metastasis (BM) resection. ...
Factors influencing discussion duration in breast cancer multidisciplinary team meetings: insights for streamlining care [0.03%]
影响乳腺癌多学科团队会议讨论时长的因素：优化护理的启示
Lejla Kočo,Wendelien B G Sanderink,Mathias Prokop et al.
Lejla Kočo et al.
Purpose: Multidisciplinary team meetings (MDTMs) in breast cancer care improve outcomes but are time-consuming and costly. This study investigates using data from the Dutch national cancer registry (NCR) and hospital elec...
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B) [0.03%]
拉贝卡利重新挑战治疗在激素受体阳性HER2阴性转移性乳腺癌患者中进展后使用过拉贝卡利联合内分泌治疗的疗效：I期AGAIN研究(WJOG14220B)结果
Meiko Nishimura,Takahiro Kogawa,Keiji Sugiyama et al.
Meiko Nishimura et al.
Purpose: In the postMONARCH trial, abemaciclib plus fulvestrant (FUL) yielded a progression-free survival (PFS) of 6.0 months in hormone receptor (HR)-positive HER2-negative metastatic breast cancer patients who progresse...
Extended applications of chest wall perforator flaps in breast surgery: case series and systematic literature review [0.03%]
胸部穿支皮瓣在乳房手术中拓展应用的病例系列及系统文献回顾
Serene Si Ning Goh,Xinyan Zhou,Qin Xiang Ng et al.
Serene Si Ning Goh et al.
Purpose: Chest wall perforator flaps (CWPFs) are integral to modern oncoplastic breast surgery, offering volume replacement without muscle sacrifice. While their role in partial breast reconstruction is established, data ...
Real-world clinical outcomes of intermediate-risk PAM50 (i-ROR) in HR+/HER2- early breast cancer and eligibility for adjuvant CDK4/6 inhibitors [0.03%]
PAM50中危型复发风险(i-ROR)激素受体阳性的人类表皮生长因子受体阴性早期乳腺癌的临床转归及 cyclin依赖性激酶4和6抑制剂的适应症
Santiago Terán,María Illia,María Carla Quevedo et al.
Santiago Terán et al.
Introduction: Risk-adapted strategies are central to early breast cancer (EBC) management, particularly in HR+/HER2 - disease. Prosigna/PAM50 combined with clinicopathologic factors refines prognosis, with clearer guidanc...
Clinicopathologic features, treatment patterns and survival outcomes of acinic cell carcinoma of the breast: a national cancer database analysis [0.03%]
全国癌症数据库分析的乳腺腺样囊性癌的临床病理特征、治疗模式和生存结果
Cher Ying Foo,Ojasav Sehrawat,Akshjot Puri et al.
Cher Ying Foo et al.
Purpose: Acinic cell carcinoma (ACC) of the breast is a rare malignancy characterized by serous acinar differentiation resembling salivary gland ACC. Although historically described as a triple-negative malignancy, its im...
Age-stratified difference in patient-reported health-related quality of life following breast cancer surgery [0.03%]
乳腺癌术后患者报告的健康相关生活质量的年龄分层差异
Claire Liu,Rebecca Warburton,Jin-Si Pao et al.
Claire Liu et al.
Purpose: To examine age-stratified changes in patient-reported health-related quality of life (HRQoL) following breast cancer surgery across surgical modalities. ...